Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
COBW domain containing 7 pseudogene (Ensembl: ENSG00000225394, also known as LOC100419812, AC106883.1) is classified as a pseudogene in humans and is not considered a functional gene nor a therapeutic target[1][2][3]. The name derives from sequence similarity to genes encoding the CobW domain—a domain involved in metal chaperoning and GTPase activity in prokaryotic species and some Eukaryote (non-human) genes[5][6]. Unlike its protein-coding paralogs or homologs, which may play roles in metal homeostasis and cobalamin (vitamin B12) biosynthesis in other organisms[5][6], this pseudogene does not have known biological functions, roles in disease, or relevance as a drug-interacting molecule, biomarker, or safety concern in humans[1][2][3]. Since it is a *pseudogene*, it is not used as a receptor, enzyme, transporter, or other classic therapeutic target molecule. The presence of “domain containing” in the name refers to a homologous region, but the gene itself is defunct with no evidence of protein-coding activity or biological relevance in human cell biology. Notes: - There is nothing fundamentally incorrect in the naming conventions, but **as a pseudogene, it is not a valid therapeutic target** and contains no known coding function or drug relevance[1][2][3]. - “COBW domain containing 7 pseudogene” should not be mistaken for active CobW domain-containing proteins (such as ZNG1F/ZNG1C)[7]; those are protein-coding and may have molecular or therapeutic relevance in other contexts[5][7]. Summary rationale: This entry describes a human pseudogene with *no protein product, no known biological function or disease involvement, and no evidence as a drug target*; hence “is_target” is false and “is_incorrect” is true (for the purposes of structured drug target databases)[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on COBW domain containing 7 pseudogene.